BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21352607)

  • 1. A role of 18F-fluorodeoxyglucose positron emission/computed tomography in a strategy for abdominal wall metastasis of colorectal mucinous adenocarcinoma developed after laparoscopic surgery.
    Funahashi K; Ushigome M; Kaneko H
    World J Surg Oncol; 2011 Feb; 9():28. PubMed ID: 21352607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
    Yang ZY; Hu SL; Shi W; Zhu BL; Xu JY; Zhang YJ
    Nucl Med Commun; 2011 Nov; 32(11):1018-25. PubMed ID: 21956489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of computed tomography and
    Kaneko M; Kawai K; Nozawa H; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Emoto S; Murono K; Ishii H; Sonoda H; Watadani T; Takao H; Abe O; Ishihara S
    Colorectal Dis; 2020 Dec; 22(12):1984-1990. PubMed ID: 32780478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
    Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Port site recurrence diagnosed by positron emission tomography after laparoscopic surgery for colon cancer.
    Kosugi C; Ono M; Saito N; Sugito M; Ito M; Murakami K; Sato K; Kotaka M; Nomura S; Arai M; Kobatake T
    Hepatogastroenterology; 2005; 52(65):1440-3. PubMed ID: 16201091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
    Murakami S; Saito H; Karino F; Kondo T; Oshita F; Ito H; Nakayama H; Yokose T; Yamada K
    Eur J Radiol; 2013 Nov; 82(11):e721-5. PubMed ID: 23988690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT in a case of malignant priapism secondary to metastasis from mucoid adenocarcinoma of the cecum.
    Sasikumar A; Harisankar CN; Bhattacharya A; Kapoor R; Mittal BR
    Clin Nucl Med; 2013 Feb; 38(2):e91-2. PubMed ID: 23334147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
    Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
    Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
    Sun L; Su XH; Guan YS; Pan WM; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Aug; 14(29):4627-32. PubMed ID: 18698676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT findings of a recurrent adenocarcinoma arising from malignant transformation of abdominal wall endometriosis.
    Jiang M; Chen P; Sun L; Huang Q; Wu H
    Clin Nucl Med; 2015 Feb; 40(2):184-5. PubMed ID: 25546222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
    Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
    Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of (18)F-FDG PET/CT to Detect Metastatic Mucinous Adenocarcinoma Within an Inguinal Hernia.
    Seo HJ; Min BW; Eo JS; Lee SI; Kang SH; Jung SY; Oh SC; Choe JG
    Nucl Med Mol Imaging; 2016 Mar; 50(1):85-9. PubMed ID: 26941865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Recurrence of Colorectal Mucinous Adenocarcinoma and Sarcoidosis on 18 F-FDG PET/CT.
    Habouzit V; Maoui K; Prevot N; Forest F; Grange R
    Clin Nucl Med; 2024 May; 49(5):475-477. PubMed ID: 38465959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined positron emission tomography and computed tomography for the detection of recurrent ovarian mucinous adenocarcinoma.
    Martínez-Román S; Ramirez PT; Oh J; Viciedo MG; MacApinlac HA
    Gynecol Oncol; 2005 Mar; 96(3):888-91. PubMed ID: 15721446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.